Skip to main content

Zevra Therapeutics, Inc.

ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001434647

In the last 90 days, Zevra Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $642.0M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Zevra Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
110
+3 vs. Q3 2024
Shares held
33.9M
+4.99M (+17.3%) vs. Q3 2024
Total value
$282.9M
+$82.1M (+40.9%) vs. Q3 2024
New holders
26
42 more added
Sold out
23
18 more reduced

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZVRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 110 institutions
Q1 2021: 51 institutionsQ2 2021: 70 institutionsQ3 2021: 70 institutionsQ4 2021: 76 institutionsQ1 2022: 82 institutionsQ2 2022: 73 institutionsQ3 2022: 69 institutionsQ4 2022: 70 institutionsQ1 2023: 61 institutionsQ2 2023: 71 institutionsQ3 2023: 77 institutionsQ4 2023: 84 institutionsQ1 2024: 89 institutionsQ2 2024: 93 institutionsQ3 2024: 108 institutionsQ4 2024: 110 institutionsQ1 2025: 111 institutionsQ2 2025: 121 institutionsQ3 2025: 166 institutionsQ4 2025: 159 institutionsQ1 2026: 148 institutionsQ2 2026: 157 institutions
Value heldQ4 2024: $282.9M
Q1 2021: $21.4MQ2 2021: $98.3MQ3 2021: $73.1MQ4 2021: $63.3MQ1 2022: $45.4MQ2 2022: $32.4MQ3 2022: $41.8MQ4 2022: $27.2MQ1 2023: $33.8MQ2 2023: $41.6MQ3 2023: $52.1MQ4 2023: $83.0MQ1 2024: $80.7MQ2 2024: $78.6MQ3 2024: $201.0MQ4 2024: $282.9MQ1 2025: $264.9MQ2 2025: $318.9MQ3 2025: $379.4MQ4 2025: $341.8MQ1 2026: $384.6MQ2 2026: $642.0M
Institutions holding ZVRA and their total value by quarter
QuarterHoldersValue
Q2 2026157$642.0M
Q1 2026148$384.6M
Q4 2025159$341.8M
Q3 2025166$379.4M
Q2 2025121$318.9M
Q1 2025111$264.9M
Q4 2024110$282.9M
Q3 2024108$201.0M
Q2 202493$78.6M
Q1 202489$80.7M
Q4 202384$83.0M
Q3 202377$52.1M
Q2 202371$41.6M
Q1 202361$33.8M
Q4 202270$27.2M
Q3 202269$41.8M
Q2 202273$32.4M
Q1 202282$45.4M
Q4 202176$63.3M
Q3 202170$73.1M
Q2 202170$98.3M
Q1 202151$21.4M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Zevra Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding ZVRA in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
State Street Corp1,172,556$9.78M0.00%+399,731+51.7%Added
Geode Capital Management, LLC1,188,120$9.91M0.00%+144,256+13.8%Added
683 Capital Management, LLC1,225,834$10.2M1.01%+834+0.1%Added
Altium Capital Management LP1,850,000$15.4M4.81%+150,000+8.8%Added
FMR LLC2,329,343$19.4M0.00%+16,141+0.7%Added
Nantahala Capital Management, LLC2,340,333$19.5M1.37%−583,688−20.0%Reduced
Vanguard Group Inc2,824,212$23.6M0.00%+68,151+2.5%Added
Adage Capital Partners GP, L.L.C.3,650,000$30.4M0.05%+3,001,000+462.4%Added
BlackRock, Inc.4,080,420$34.0M0.00%+958,661+30.7%Added
Woodline Partners LP4,139,593$34.5M0.23%+90,940+2.2%Added
Vestal Point Capital, LP0$00.00%−525,000−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−386,245−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−350,000−100.0%Sold out
Brandywine Global Investment Management, LLC0$00.00%−177,900−100.0%Sold out
Jane Street Group, LLC0$00.00%−152,907−100.0%Sold out
Monashee Investment Management LLC0$00.00%−150,000−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−95,143−100.0%Sold out
Caption Management, LLC0$00.00%−62,000−100.0%Sold out
Marshall Wace, LLP0$00.00%−52,077−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−24,800−100.0%Sold out
GTS Securities LLC0$00.00%−24,103−100.0%Sold out
Valence8 US LP0$00.00%−21,596−100.0%Sold out
Virtu Financial LLC0$00.00%−18,367−100.0%Sold out
Simplex Trading, LLC0$00.00%−16,380−100.0%Sold out
XTX Topco Ltd0$00.00%−13,551−100.0%Sold out
LPL Financial LLC0$00.00%−13,515−100.0%Sold out
Stephens Consulting, LLC0$00.00%−1,000−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−600−100.0%Sold out
Ronald Blue Trust, Inc.0$00.00%−121−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−57−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−40−100.0%Sold out
Thompson Investment Management, Inc.0$00.00%−1−100.0%Sold out
International Assets Investment Management, LLC0$00.00%−6,940−100.0%Sold out
Raymond James Financial Services Advisors, Inc.––––Not filed